Deciphera Pharmaceuticals, Inc. (DCPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.72 |
| Open | 14.67 |
| Bid | 14.20 x 200 |
| Ask | 14.27 x 300 |
| Day's range | 14.19 - 14.91 |
| 52-week range | 9.90 - 17.73 |
| Volume | |
| Avg. volume | 528,025 |
| Market cap | 1.15B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.29 |
| Earnings date | 01 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 24.20 |
Business WireDeciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
WALTHAM, Mass., April 09, 2024--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16, 2024 at 11:30 AM ET.
Simply Wall St.Companies Like Deciphera Pharmaceuticals (NASDAQ:DCPH) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
ZacksWhy Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?
Biogen Inc. (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.